Awakn Life Sciences (AWKNF) Stock Price, News & Analysis

Company Overview

Awakn Life Sciences Corp., a biotechnology company, engages in the researching, developing, operations, and delivering of psychedelic therapeutics to treat addiction and other mental health conditions in the United Kingdom and Europe. The company has a collaboration agreement with the University of Exeter for exploring the use of ketamine-assisted therapy to treat Severe AUD. Awakn Life Sciences Corp. is headquartered in Toronto, Canada.

Key Stats

• Today's Range: $0.07 to $0.07
• 50-Day Range: $0.07 to $0.07
• 52-Week Range: $0.05 to $0.19
• Volume: N/A
• Average Volume: 16,563 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

AWKNF Stock Analysis - Frequently Asked Questions

How have AWKNF shares performed this year?

Awakn Life Sciences' stock was trading at $0.0650 at the beginning of 2025. Since then, AWKNF stock has increased by 0.0% and is now trading at $0.0650.

How do I buy shares of Awakn Life Sciences?

Shares of AWKNF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:AWKNF
• CIK: N/A
• Web: awaknlifesciences.com
• Phone: N/A
• Fax: N/A
• Employees: 44
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A